A battle royale ensued in 2013 in the still-emerging US market for left ventricular assist devices (LVADs) between the only two companies holding FDA approvals, Thoratec Corp. and HeartWare International Inc. The pair is racing to win physician favor and secure commercial sites and unit sales across the US and worldwide, with Thoratec holding on to its market-dominating position at present. (See Also see "Pressure Builds In Ventricular Assist Market" - Medtech Insight, 27 February, 2013.).
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?